Corrigendum to ‘Butaselen prevents hepatocarcinogenesis and progression through inhibiting thioredoxin reductase activity’ [Redox Biol. 14 (2018) 237–249]
Xiaoqing Zheng,
Weiwei Ma,
Ruoxuan Sun,
Hanwei Yin,
Fei Lin,
Yuxi Liu,
Wei Xu,
Huihui Zeng
Affiliations
Xiaoqing Zheng
State Key Laboratory of Natural and Biomimetic Drugs, NO.38, Xueyuan Road, Beijing, 100191, PR China; Department of Chemical Biology, School of Pharmaceutical Sciences, Peking University, NO.38, Xueyuan Road, Beijing, 100191, PR China
Weiwei Ma
State Key Laboratory of Natural and Biomimetic Drugs, NO.38, Xueyuan Road, Beijing, 100191, PR China; Department of Chemical Biology, School of Pharmaceutical Sciences, Peking University, NO.38, Xueyuan Road, Beijing, 100191, PR China
Ruoxuan Sun
State Key Laboratory of Natural and Biomimetic Drugs, NO.38, Xueyuan Road, Beijing, 100191, PR China; Department of Chemical Biology, School of Pharmaceutical Sciences, Peking University, NO.38, Xueyuan Road, Beijing, 100191, PR China
Hanwei Yin
Keaise Center for Clinical Laboratory, NO.666, Gaoxin Road, Wuhan, 430000, PR China
Fei Lin
National Institutes for Food and Drug Control, NO.2, Tiantanxili, Beijing, 100050, China
Yuxi Liu
State Key Laboratory of Natural and Biomimetic Drugs, NO.38, Xueyuan Road, Beijing, 100191, PR China; Department of Chemical Biology, School of Pharmaceutical Sciences, Peking University, NO.38, Xueyuan Road, Beijing, 100191, PR China
Wei Xu
Department of Pharmacology and Molecular Sciences, Johns Hopkins University School of Medicine, Baltimore, MD, 21287, USA
Huihui Zeng
State Key Laboratory of Natural and Biomimetic Drugs, NO.38, Xueyuan Road, Beijing, 100191, PR China; Department of Chemical Biology, School of Pharmaceutical Sciences, Peking University, NO.38, Xueyuan Road, Beijing, 100191, PR China; Corresponding author. State Key Laboratory of Natural and Biomimetic Drugs, Department of Chemical Biology, School of Pharmaceutical Sciences, Peking University, No.38 Xueyuan Road, Beijing, 100191, PR China.
